MedTrace Logo

Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients

NCT00507052 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-07-25

No results posted yet for this study

Summary

In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on Residual Renal Function.

The aim of our study is to investigate the effect of N-acetylsysteine on RRF in prevalent HD patients.

Conditions

  • Hemodialysis
  • Renal Failure

Interventions

DRUG

N-acetylcysteine

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Leonid S Feldman, MD · Assaf Harofeh MC

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507052 on ClinicalTrials.gov